Skip to main content

Year: 2021

Capital Power highlights strong cash flows and dividend growth guidance to 2025 at Investor Day

Announces acquisition of a portfolio of renewable development sites, construction plans for phase 2 of Halkirk Wind and decarbonization EDMONTON, Alberta, Dec. 02, 2021 (GLOBE NEWSWIRE) — At its 13th annual Investor Day event being held virtually today, Capital Power Corporation (TSX: CPX) (“Capital Power” or “the Company”) will review its financial outlook and highlight progress on its decarbonization plans, including acquisition of a portfolio of renewable development sites, construction plans for phase 2 of Halkirk Wind, addition of battery storage to its Genesee 1 and 2 repowering project, and evaluation of carbon capture and storage solutions. “Capital Power continues its leadership position in the Alberta power market with the announcements we are making today at our Investor Day,” said Brian Vaasjo, President and CEO of...

Continue reading

LGBTQ Loyalty announces Deborah Fuhr to join board of directors

The ETF industry leader will join the company in expanding its mission to raise minority voices in investing and corporate America WILTON MANORS, Fla., Dec. 02, 2021 (GLOBE NEWSWIRE) — LGBTQ Loyalty Holdings, Inc. (OTC PINK: LFAP) (“LGBTQ Loyalty”) (“the Company ”), a diversity- and inclusion-driven financial methodology and data company, is pleased to announce the addition of ETF industry leader Deborah Fuhr to the board of directors. “On behalf of the board of directors, it’s exciting to have Deborah join. She has asserted herself as a leader in ETF dialogue, research, trends and media globally,” said Bobby Blair, CEO of LGBTQ Loyalty Holdings. “We look forward to joining forces with Deborah to propel our Advancing Equality mission even further.” Deborah holds many positions across the ETF space, as the owner, managing...

Continue reading

Premier Health Announces the Appointment of Eric Dupont as Its New CTO

MONTRÉAL, Dec. 02, 2021 (GLOBE NEWSWIRE) — Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a leading Canadian Healthtech company, announces the appointment of Eric Dupont as the Corporation’s new Chief Technology Officer, effective immediately. “We are very excited to have Eric join Premier Health. His hiring follows our recent technology roadmap exercise, and he will be an important member of the Corporation’s senior leadership team as we continue to expand and execute our growth strategy,” said Martin Legault, Chief Executive Officer. “Eric’s wide experience will benefit Premier Health and its shareholders at many levels.” he added. Eric is a seasoned professional with over 25 years of information technology experience. Over the years, he has developed an expertise in the definition of technology...

Continue reading

Enphase Energy Announces Participation in Arizona Public Service Pilot Grid Services Program

Incentive can pay up to $3,750 for qualified new IQ™ Battery 10 owners FREMONT, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world’s leading supplier of microinverter-based solar and battery systems, today announced its participation in Arizona Public Service’s (APS) residential battery pilot grid services program. The program offers homeowners with Enphase IQ Batteries in APS’s service territory two ways to participate and earn money through one-time, upfront incentives. Customers who sign up for the program and simply share their data with APS, including basic information about them and their Enphase Energy System, will earn $500 per installed kilowatt of battery capacity with a cap of $2,500 per home. Alternatively, homeowners can enroll in the...

Continue reading

Infinera to Participate in Upcoming Raymond James Technology Investors Conference

SAN JOSE, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today that it will participate in the following webcasted investor conference: Raymond James Technology Investors ConferenceDate: Monday, December 6, 2021Presentation: 3:10pm EST / 12:10pm PSTSpeakers: David Heard, CEO; Nancy Erba, CFO; Amitabh Passi, Head of Investor RelationsWebcast: investors.infinera.com and click on “Events” Contacts: Infinera Media: Anna VueTel. +1 (916) 595-8157avue@infinera.com Infinera Investors:Amitabh PassiTel. +1 (669) 295-1489apassi@infinera.com About InfineraInfinera is a global supplier of innovative open optical networking solutions that enable carriers, cloud operators, governments, and enterprises to scale network bandwidth, accelerate service innovation, and automate network operations. Infinera solutions deliver...

Continue reading

Immutep Reports Good Safety from First Five Patients in Triple Combination Therapy Efti Study, Insight-003

SYDNEY, AUSTRALIA, Dec. 02, 2021 (GLOBE NEWSWIRE) —  Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune disease, announces the first five patients have been treated in the INSIGHT-003 study. No additional safety signals have been observed in the study which is the first time a triple combination therapy consisting of eftilagimod alpha (“efti”) and an existing approved standard of care combination of chemotherapy (carboplatin) and an anti-PD-1 therapy has been administered. Lead investigator, Prof. Dr. Salah-Eddin Al-Batran of the Institute of Clinical Cancer Research IKF said: “The INSIGHT-003 study has commenced well. We are very pleased with the safety of the triple combination so far and all patients...

Continue reading

Cocrystal Pharma to Discuss Progress with COVID-19 Antiviral Programs and Clinical Strategy During Noble Capital Markets’ Channelchek Virtual Roadshow

BOTHELL, Wash., Dec. 02, 2021 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that President and interim CEO Sam Lee, Ph.D. and CFO and interim CEO James Martin will present a company overview in the Noble Capital Markets Virtual Roadshow Series presented by Channelchek. The live presentation will be by webcast on Wednesday, December 8, 2021 at 1:00 p.m. Eastern time (10:00 a.m. Pacific time). Registration for the webcast presentation is available here. The Cocrystal company overview will be followed by a question-and-answer session moderated by Noble Capital Markets Senior Research analyst Robert LeBoyer and will feature questions submitted by the audience. A replay of the webcast will be available within three business days of the live presentation. “We are working diligently...

Continue reading

Gastro Obscura and igourmet Launch Limited Edition Culinary Wonders Box

The Gastro Obscura / igourmet® collaboration box is an edible journey including 13 culinary wonders from around the world. NEW YORK, Dec. 02, 2021 (GLOBE NEWSWIRE) — Gastro Obscura, the premier destination for wondrous, intriguing, and surprising food and drink around the world created by the ever-curious minds behind Atlas Obscura, and igourmet.com, the premier online retailer of the largest assortment of high-quality specialty foods sourced from artisan food producers, are uniting forces to create the ultimate food experience for the curious eater – a limited edition “Taste of Gastro Obscura Box.” This gift box includes 13 hard to find snacks from around the world. Certain items may be familiar to you; others, you may have never seen before. Each one has a story, and everything is tasty.⁠ Gastro Obscura co-author Dylan...

Continue reading

Oncocyte to Present New Data on DetermaIO Clinical Test for Immunotherapy Response in Triple Negative Breast Cancer at San Antonio Breast Cancer Symposium 2021

Spotlight poster presentation indicates DetermaIO assay and algorithm is robust across multiple diagnostic platforms, confirms that test predicts response to immunotherapy (atezolizumab) benefit Oncocyte will support a Continuing Medical Education event on Immunotherapy Biomarkers at SABCS, hosting key opinion leaders from the United States and Europe IRVINE, Calif., Dec. 02, 2021 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company with the mission to improve patient outcomes by providing clear insights that inform critical decisions in the diagnosis, treatment, and monitoring of cancer, today announced that it will present new data from ongoing clinical research evaluating the 27-gene DetermaIO™ test at the 2021 San Antonio Breast Cancer Symposium (SABCS 2021), taking place December 7-10, 2021. Recently...

Continue reading

Suspected E-Commerce Fraud Attempt Rates Between Thanksgiving and Cyber Monday Increase 25% Compared to the Rest of the Year

TransUnion research finds one quarter of consumers are more concerned about becoming a victim of digital fraud this holiday season compared to last year CHICAGO, Dec. 02, 2021 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) released new findings today around global e-commerce fraud trends that occurred during the busiest period of the 2021 holiday shopping season. The analysis found 17.46% of all global e-commerce transactions between Thanksgiving and Cyber Monday were potentially fraudulent1. Those numbers were slightly higher in the U.S. where 19.66% were suspected fraudulent. The number of suspected e-commerce fraud attempts during the 2021 holiday shopping season was also a 25% increase over the 15.73% of fraud attempts observed earlier in the year (January 1 to November 29). Globally, the percentage of suspected fraudulent e-commerce...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.